~~<i id='4409B0A585'><strike id='4409B0A585'><tt id='4409B0A585'><pre id='4409B0A585'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：focus 2025-10-06 17:21:14 Page View：8879

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： J&J lung cancer data amount to new salvo against AstraZeneca
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

explore

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Asbestos, a deadly carcinogen, banned by EPA

EPAAdministratorMichaelReganspeaksonFeb.16,2024,inEastPalestine,Ohio.TheEPAhasannouncedacomprehensiv

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

CZI to create biohub to build anti

PriscillaChanandMarkZuckerbergappearvirtuallyatthe2023STATSummit.STATMetafounderMarkZuckerbergandhis